Gut microbiota modulate the immune effect against hepatitis B virus infection (Q35745517)

10 August 2017

Gut microbiota modulate the immune effect against hepatitis B virus infection (English)

1 reference

10 August 2017

1 reference

D Xu

1

1 reference

10 August 2017

Y Huang

series ordinal

2

1 reference

10 August 2017

J Wang

series ordinal

3

1 reference

10 August 2017

language of work or name

1 reference

14 August 2015

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

10 August 2017

1 reference

10 August 2017

34

1 reference

10 August 2017

2139-2147

1 reference

10 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-015-2464-0

10 August 2017

0 references

cites work

New insights into how HBV manipulates the innate immune response to establish acute and persistent infection

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

The role of the adaptive immune system in regulation of gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Gut microbiota and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Microbiota regulates immune defense against respiratory tract influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Symbiotic commensal bacteria direct maturation of the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Gut microbiota and probiotics in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

The impact of differential antiviral immunity in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Global epidemiology of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Hepatitis B infection: current concepts and future challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Role of placental tissues in the intrauterine transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Innate immune response and hepatic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Acute liver failure: mechanisms of immune-mediated liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Innate immune responses in hepatitis B virus (HBV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Hepatitis B Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Innate immunity of the newborn: basic mechanisms and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Reduced levels of antimicrobial proteins and peptides in human cord blood plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Maturation of Toll-like receptor 1-4 responsiveness during early life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Dendritic cells in uninfected infants born to hepatitis B virus-positive mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Involvement of Th17 and Th1 effector responses in patients with Hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Who determines the outcomes of HBV exposure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Viral and nonviral elements in potexvirus replication and movement and in antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Immunobiology of hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Innate and adaptive immune responses in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Diagnostic criteria of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Occult hepatitis B virus infection in patients with autoimmune liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Gut-liver axis and sensing microbes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

The intestinal microbiota and microenvironment in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Role of gut microbiota in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Localisation and trafficking of Toll-like receptors: an important mode of regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Role of the intestinal microbiome in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Interactions between the intestinal microbiome and liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

The gut microbiota and the liver. Pathophysiological and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

The gut microbiota and the liver: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Microbiota-liver axis in hepatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Investigation of the intestinal microbiota in preterm infants using different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Human nutrition, the gut microbiome and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

TLR3 deficiency in patients with herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Linking intestinal homeostasis and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Innate immunity and alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

The role of hepatic immune regulation in systemic immunity to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

NK cells: a double-edged sword in chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Biological activities of lipoteichoic acid and peptidoglycan-teichoic acid of Bacillus subtilis 168 (Marburg).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Therapeutic depletion of natural killer cells controls persistent infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Gut microbiota elicits a protective immune response against malaria transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Long-term protective effects of hepatitis A vaccines. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Hepatitis E: the forgotten virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Immunopathogenesis of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Antibiotics, microbiota, and immune defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Altered early infant gut microbiota in children developing allergy up to 5 years of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-015-2464-0

Antioxidant protective effects of lactitol against endotoxemia in patients with chronic viral hepatitis

21 January 2018

1 reference

12 December 2020

Hepatitis B virus infection

1 reference

12 December 2020

Acquisition of adult-like TLR4 and TLR9 responses during the first year of life

1 reference

12 December 2020

Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis

1 reference

12 December 2020

Expression of Toll-like receptors by neonatal leukocytes

1 reference

12 December 2020

Natural killer cells act as rheostats modulating antiviral T cells

1 reference

12 December 2020

Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure

1 reference

12 December 2020

Hepatitis B in pregnancy: a concise review of neonatal vertical transmission and antiviral prophylaxis

1 reference

12 December 2020

Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese.

1 reference

12 December 2020

Recognition of lipopolysaccharide pattern by TLR4 complexes

1 reference

12 December 2020

10.1007/S10096-015-2464-0

Identifiers

DOI

1 reference

10 August 2017

1 reference